June 2026
The global T-cell immunotherapy market size is estimated to hit around USD 29.45 billion by 2035 increasing from USD 8.43 billion in 2025, with a CAGR of 13.33%.
June 2026
The global engineered TCR (T-Cell Receptor) therapy market is growing as immunotherapies advance for cancer and infectious disease treatment.
June 2026
The US CAR T-cell therapy market size was evaluated at USD 2,299.97 million in 2025 and is predicted to hit around USD 11,510.04 million by 2035, growing at a CAGR of 17.47%.
June 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
May 2026
The global CAR T-cell therapy market size is calculated at USD 5,206.15 million in 2025 and is projected to surpass around USD 26,982.3 million by 2035 with a solid CAGR of 17.88%.
April 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.66 billion in 2025, with a CAGR of 9.70%.
April 2026
The global radioimmunotherapy market size was evaluated at USD 3.13 billion in 2025 and is expected to attain around USD 14.36 billion by 2035, with a CAGR of 16.46%.
April 2026
The global T-cell engagers market size was evaluated at USD 7.70 billion in 2025 and is predicted to hit around USD 32.53 billion by 2035, growing at a CAGR of 15.50%.
February 2026
The global T-cell therapy market size is reached at USD 10.30 billion in 2025 and it is expected to hit around USD 196.21 billion by 2035 with a CAGR of 34.27%.
February 2026
The cancer immunotherapy market size is calculated at USD 136.39 billion in 2025 and is projected to hit around USD 367.63 billion by 2035, at a CAGR of 10.42%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com